全球抑郁癥發(fā)展分析報(bào)告-培訓(xùn)課件外文版2024.5

INDUSTRIES

&

MARKETSDepressive

Disorders:

marketdata

&

analysisMarket

InsightsreportJuly2023Table

of

ContentsOverviewAppendixSummary567ProductOverviewAuthor1920MarketDefinitionKeyTakeawaysMarket

NumbersRevenue91215AverageRevenue

per

PatientPatients2MARKET

INSIGHTSThis

report

is

part

ofour

Market

Insights

productGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,

regional,country,

and/orstatelevel.

Accessourdatavia

webinterface,download(XLS,

PDF,PPT),or

reports.Benefitfromour48-hourcustomerservice

guarantee.?

10

sectors:

advertising&media,consumers,countries,digital

sector,finance,health,

industrialsector,mobility,andtechnology?

1,000+

markets,

e.g.,

FinTech,Food,or

Robotics?

KPIs,

e.g.,

revenue,marketshares,prices,andvolume?

Features:Compare

countries®ions,

change

currencies,

selectvisualizations,

and/or

customize

downloads?

Usecases:

sales

planning,

investment

decision

support,resourceallocation,andportfolio

management10sectors190+geographicalentities1,000+markets400+reportsFind

out

more

on:https://www.Goto

Market

Insightscom/outlook/3CHAPTER

1OverviewThe

Depressive

Disorders

segment

in

the

Mental

Health

market

represents

themarketfor

the

drug

salesOverview:

SummarySummaryDepressive

disorders

are

acommon

mental

health

disorder

thatcanbediagnosedinpatientsof

allagegroups.

There

are

nearly

300

million

peoplearoundthe

world

diagnosed

withdepressive

disorders.

Amajority

ofthese

casesarebeing

treated

withpsychological

treatments

and

only

insome

severe

casesantidepressantmedications

areprescribed.theirlifestyle

androutine.

However,

thechangesstillnegatively

affectedmanypeople's

mental

health.Market

revenues

inindividualcountries

arealsogreatlyinfluenced

bydrugprices,

which

canvary

from

onecountry

tothe

otherdepending

ontheprotection

of

thedruginthose

countries.Theincreasing

prevalence

ofvarious

typesofdepressive

disorders

isone

ofthemaincontributers

when

itcomes

to

therise

inantidepressant

drugsales.

Ontheone

hand,

the

market

ispositively

influencedbynew

productlaunchesandapprovals.

Ontheotherhand,

the

market

isalsobeingnegatively

affectedbythelossof

patentprotection

insome

cases.Duetothe

rise

indiagnosed

depressive

disorder

cases

thatfollowed

aftermanycountries

went

into

lockdown

and

enforced

social

distancingmeasures,

themarket

sawarise

inworldwide

antidepressant

drugsalesin2020.

Although

ittook

some

timefor

people

to

adaptto

theseimpositions,

theywere

abletoadjust5Sources:Market

Insights

2023Depressive

Disorders

are

an

important

part

of

the

Mental

Health

marketOverview:

Market

DefinitionMarket

definitionDepressive

disorders

are

acommon

typeof

mental

illness.

Symptoms

includedepressive

moods

suchasfeeling

sad,low

concentration,

low

self-worth,

loss

ofinterest

inactivities,and,insome

cases,

thoughts

ofsuicide.

Common

treatmentsfordepressive

disorders

includepsychological

treatments

suchaspsychotherapy,behavioral

therapy,and

antidepressant

medication.Company

examples:

Novartis

AG,Pfizer,

Bristol-Myers

Squibb,

GlaxoSmithKline,Patheon

Inc,and

SandozInc.TheDepressive

Disorders

market

intheMental

Healthmarket

represents

themarket

forantidepressant

drugsales.

Different

typesofantidepressants

areusuallyprescribed

forthe

treatment

of

mildtoserious

casesof

depression,

e.g.,selective

serotonin

reuptake

inhibitors(SSRIs),

serotonin

norepinephrine

reuptakeinhibitor(SNRIs),serotonin

modulators,

aswell

astricyclic

and

tetracyclicantidepressants.Market

valuesrepresent

the

revenues

generated

bymanufacturers

and

are

basedon

retail

prices

foreach

drugcategory

includingalldrugs,regardless

ofwhethertheyarereimbursed

or

not.6Sources:Market

Insights

2023Depressive

Disorders

accounted

for

57.22%

of

the

Mental

Health

marketrevenue

in

2022Overview:

Key

Takeaways

and

inscope

/outof

scopeKeyTakeawaysInscopeOutof

scopeRevenue

intheDepressive

Disorders

market

isprojected

toreach

US$21.09bn

in2023.Thissegment

includes:Thissegment

excludes:Revenue

isexpected

toshow

anannualgrowth

rate(CAGR

(1)

2023-2028)

of0.64%,resultinginamarket

volume

of

US$21.77bn

by2028.?Antidepressant

drugs?Psychotherapy?Selective

serotonin

reuptakeinhibitors(SSRIs)?Mood

stabilizersInglobalcomparison,

most

revenue

will

begenerated

in

theUnitedStates(US$5,554.00m

in2023).?Anti-anxietyandstimulantmedications?Serotonin

norepinephrine

reuptakeinhibitor(SNRIs)Inrelation

to

totalpopulation

figures,per

person

revenues

of

US$65.69

aregenerated

in2023.?Behavioral

therapy?Serotonin

modulators?Tricyclicandtetracyclicantidepressants7Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:CHAPTER

2Market

NumbersDepressive

Disorders

revenue

is

estimated

to

increase

at

a

CAGR(1)

of

1.1%

from2016

to

2028Market

Size:

Globalrevenue

forecast

inbillionUS$+1.1%(1)21.721.821.521.621.321.120.820.620.419.419.319.419.120162017201820192020202120222023202420252026202720289Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:With

revenue

of

8.4

billion

US$,

Americas

is

the

biggest

market

among

selectedregions,

in

2022Market

Size:

Regional

Comparison

(1/2)revenue

forecast

inbillionUS$-0.01%(1)8.48.4+1.2%(1)+1.5%(1)6.26.05.85.5+0.9%(1)+0.9%(1)0.80.80.40.42022202820222028202220282022202820222028EuropeAfricaAmericasAsiaAustralia10

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

revenue

of

5.6

billion

US$,

United

States

is

the

biggest

market

amongselected

countries,

in

2022Market

Size:

Regional

Comparison

(2/2)revenue

forecast

inbillionUS$-0.4%(1)5.65.5+2.0%(1)+2.2%(1)-0.6%(1)1.9+0.5%(1)1.71.31.21.11.20.80.82022202820222028202220282022202820222028United

StatesChinaJapanCanadaFrance11

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023The

average

revenue

per

patient

in

the

Depressive

Disorders

segment

isestimated

to

decrease

from2016

to

2028Market

Size:

Globalaverage

revenue

perpatientforecast

inUS$8072.072.571.370.968.367.466.470605040302010065.764.863.762.661.560.4201620172018201920202021202220232024202520262027202812

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Australia

has

the

biggest

average

revenue

per

patient

in

2022Market

Size:

Regional

Comparison

(1/2)average

revenue

perpatientforecast

inUS$285.5238.9300

280.7280.6218.4263.5213.0258.7200.4154.8249.3193.0158.0247.8245.7243.4240.9238.4235.5153.7236.0233.625020015010050186.4157.4181.6158.1177.4157.8173.7156.9170.5155.8167.6154.4164.9153.0162.9161.3155.132.813.432.912.633.112.233.611.833.911.434.011.133.910.733.710.333.49.933.19.529.413.231.413.328.814.802016201720182019202020212022202320242025202620272028AustraliaAmericasEuropeAsiaAfrica13

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

an

average

revenue

per

patient

of

307.4

US$,

United

States

is

the

biggestmarket

among

selected

countries,

in

2022Market

Size:

Regional

Comparison

(2/2)average

revenue

perpatientforecast

inUS$450406.0402.2400350363.0355.2343.4249.1315.7250.2247.0216.8307.4297.2246.6289.1247.5228.4217.9282.6277.4248.2217.8217.1269.5300

271.4265.7269.8271.7270.1273.1248.1213.1215.8266.1268.3248.0223.0217.9240.5244.9214.6247.8214.2208.8250200150100252.7211.9241.6211.1234.3217.0225.0219.1215.039.942.543.343.944.444.836.038.541.431.533.226.350

23.102016201720182019202020212022202320242025202620272028UnitedStatesGermanyUnitedKingdomFranceChina14

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Depressive

Disorder

patients

are

estimated

to

increase

from

2016

to

2028Market

Size:

Globalpatientsforecast

inmillions400360.6352.8345.0337.135030025020015010050329.1321.0313.0304.9298.2274.0271.2268.1265.10201620172018201920202021202220232024202520262027202815

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023In2022,

Asia

has

more

Depressive

Disorder

patients

compared

to

otherselected

regionsMarket

Size:

Regional

Comparison

(1/2)patientsforecast

inmillions200182.384.8179.3176.4173.474.7170.5167.5164.6161.8158.8145.6146.8147.9144.31501005081.478.071.447.237.91.568.146.137.21.564.844.936.61.461.643.659.242.753.138.951.738.650.740.41.649.037.950.338.248.238.61.549.139.21.649.939.81.635.41.435.91.432.31.232.41.232.51.232.21.202016201720182019202020212022202320242025202620272028AsiaAfricaAmericasEuropeAustralia16

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

patients

of

42.2

million,

China

is

the

biggestmarket

among

selectedcountries,

in

2022Market

Size:

Regional

Comparison

(2/2)patientsforecast

inmillions4540353025201510542.017.342.117.642.218.242.218.742.219.142.219.542.219.842.220.142.220.341.541.715.741.715.841.415.53.215.63.13.13.43.43.13.43.43.520243.520263.520253.520273.52028020162017201820192020202120222023GermanyChinaUnited

States17

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023CHAPTER

3AppendixMARKET

INSIGHTSMarket

Insights

–

market

data,forecasts,

and

qualitative

insightsGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,

regional,country,

and/orstatelevel.

Accessourdatavia

webinterface,download(XLS,

PDF,PPT),or

reports.Benefitfromour48-hourcustomerservice

guarantee.?

10

sectors:

advertising&media,consumers,countries,digital

sector,finance,health,

i